On April 22, 2026, Amneal Pharmaceuticals announced its strategic acquisition of Kashiv BioSciences for $1.1 billion. This move positions Amneal... Read more
Tag: #M&A
Eli Lilly enters $7 billion agreement to acquire Kelonia Therapeutics
Eli Lilly has entered into a definitive agreement to acquire Kelonia Therapeutics for potential consideration of up to $7 billion.... Read more
UCB pivots to cell therapy with $1.2B acquisition of Neurona Therapeutics
Belgian pharmaceutical giant UCB announced on Friday its acquisition of Neurona Therapeutics for up to $1.2 billion. The move highlights... Read more
Vir Biotechnology completes Astellas deal to advance prostate cancer immunotherapy
Vir Biotechnology has officially entered into a global strategic collaboration with Astellas Pharma. The agreement focuses on the co-development and... Read more
Eli Lilly expands ADC capabilities with $300 million CrossBridge Bio acquisition
Eli Lilly has finalized a deal to acquire Houston-based startup CrossBridge Bio, marking its latest investment in the rapidly evolving... Read more
Obsidian Therapeutics to go public via $350 million merger with Galera
Obsidian Therapeutics and Galera Therapeutics have entered into a definitive all-stock merger agreement, supported by $350 million in concurrent private... Read more
Sun Pharma readies $12B binding offer for Organon
Indian pharmaceutical giant Sun Pharmaceutical is reportedly finalizing a binding offer to acquire Organon, a women's health-focused Merck & Co.... Read more
CapVest completes majority acquisition of global pharma leader STADA
CapVest Partners LLP has officially announced the completion of its acquisition of a majority stake in STADA Arzneimittel AG, a... Read more
Gilead Sciences acquires biotech firm Tubulis in a deal worth up to $5 billion
Gilead Sciences has announced an agreement to acquire Tubulis, a German biotechnology startup, in a transaction valued at potentially $5... Read more








